Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

132 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Low- versus standard-dose post-transplant cyclophosphamide as GVHD prophylaxis for haploidentical transplantation.
Fuji S, Sugita J, Najima Y, Konishi T, Tanaka T, Ohigashi H, Eto T, Nagafuji K, Hiramoto N, Matsuoka KI, Maruyama Y, Ota S, Ishikawa J, Kawakita T, Akasaka T, Kamimura T, Hino M, Fukuda T, Atsuta Y, Yakushijin K. Fuji S, et al. Among authors: hiramoto n. Br J Haematol. 2024 Mar;204(3):959-966. doi: 10.1111/bjh.19228. Epub 2023 Nov 30. Br J Haematol. 2024. PMID: 38037468
Severe short-term adverse events in related bone marrow or peripheral blood stem cell donors.
Yanagisawa R, Hirakawa T, Doki N, Ikegame K, Matsuoka KI, Fukuda T, Nakamae H, Ota S, Hiramoto N, Ishikawa J, Ara T, Tanaka M, Koga Y, Kawakita T, Maruyama Y, Kanda Y, Hino M, Atsuta Y, Yabe H, Tsukada N. Yanagisawa R, et al. Among authors: hiramoto n. Int J Hematol. 2023 Mar;117(3):421-427. doi: 10.1007/s12185-022-03489-4. Epub 2022 Nov 20. Int J Hematol. 2023. PMID: 36403180
Tandem autologous stem cell transplantation in elderly patients with myeloma: A multicenter retrospective analysis.
Suzuki K, Mizuno S, Shimazu Y, Fuchida SI, Hagiwara S, Itagaki M, Nishiwaki K, Hangaishi A, Karasuno T, Kikuchi T, Shimizu M, Nishikawa A, Kobayashi T, Sunami K, Hiramoto N, Uchiyama H, Maruyama Y, Kanda Y, Ichinohe T, Atsuta Y, Yano S, Kawamura K; Working Group of the Japan Society; for Transplantation and Cellular Therapy. Suzuki K, et al. Among authors: hiramoto n. Eur J Haematol. 2023 Apr;110(4):444-454. doi: 10.1111/ejh.13922. Epub 2023 Jan 17. Eur J Haematol. 2023. PMID: 36597575
Adverse impact of delay of platelet recovery after autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma and multiple myeloma.
Okada Y, Kimura F, Kurita N, Takahashi H, Shimazu Y, Mizuno S, Uchida N, Kataoka K, Hiramoto N, Ota S, Kako S, Tsukada N, Kanda Y, Kurahashi S, Doki N, Nishikawa A, Kim SW, Hangaishi A, Kanda J, Fukuda T, Atsuta Y, Kondo E, Kawamura K, Nakasone H. Okada Y, et al. Among authors: hiramoto n. Cytotherapy. 2023 Nov;25(11):1212-1219. doi: 10.1016/j.jcyt.2023.05.015. Epub 2023 Jun 24. Cytotherapy. 2023. PMID: 37354150
External validation and extended application of the transplant conditioning intensity score in acute myeloid leukemia.
Yanada M, Shimomura Y, Mizuno S, Matsuda K, Kondo T, Doki N, Tanaka M, Fukuda T, Ara T, Uchida N, Onizuka M, Sawa M, Ozawa Y, Hiramoto N, Ota S, Kanda J, Kanda Y, Ichinohe T, Okamoto S, Atsuta Y, Konuma T. Yanada M, et al. Among authors: hiramoto n. Bone Marrow Transplant. 2023 Oct;58(10):1096-1103. doi: 10.1038/s41409-023-02037-w. Epub 2023 Jul 13. Bone Marrow Transplant. 2023. PMID: 37443251
Efficacy of Autologous Stem Cell Transplantation for Myeloma Patients with Suboptimal Response: A Multicenter Retrospective Analysis.
Suzuki K, Shimazu Y, Minakata D, Ikeda T, Takahashi H, Tsukada N, Kanda Y, Doki N, Nishiwaki K, Miwa A, Sawa M, Kataoka K, Hiramoto N, Ota S, Itagaki M, Ichinohe T, Atsuta Y, Yano S, Kawamura K; working group of the Japan Society for Transplantation and Cellular Therapy. Suzuki K, et al. Among authors: hiramoto n. Transplant Cell Ther. 2023 Nov;29(11):688.e1-688.e13. doi: 10.1016/j.jtct.2023.08.006. Epub 2023 Aug 11. Transplant Cell Ther. 2023. PMID: 37574125
Comparison of Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide versus Umbilical Cord Blood Transplantation in Adult Patients with Aplastic Anemia.
Onishi Y, Mori T, Yamazaki H, Hiramoto N, Zaimoku Y, Kanaya M, Matsue K, Onizuka M, Aotsuka N, Uchida N, Onodera K, Kanda J, Nakamae H, Yamamoto R, Kuriyama T, Kimura T, Ichinohe T, Atsuta Y; Adult Aplastic Anemia Working Group of the Japanese Society for Transplantation and Cellular Therapy. Onishi Y, et al. Among authors: hiramoto n. Transplant Cell Ther. 2023 Dec;29(12):766.e1-766.e8. doi: 10.1016/j.jtct.2023.09.009. Epub 2023 Sep 18. Transplant Cell Ther. 2023. PMID: 37730121
Comparison of MEAM, MCEC and LEED high-dose chemotherapy followed by autologous stem cell transplantation in relapsed/refractory diffuse large B-cell lymphoma: data from the Japan Society for Hematopoietic and Cellular Therapy Registry.
Koresawa-Shimizu R, Suzuki R, Uehara Y, Hiramoto N, Sawa M, Fukuda T, Kataoka K, Kanda Y, Oyake T, Kubota Y, Uchida N, Yano S, Kobayashi H, Tanaka J, Atsuta Y, Kondo E. Koresawa-Shimizu R, et al. Among authors: hiramoto n. Bone Marrow Transplant. 2024 Jan;59(1):125-127. doi: 10.1038/s41409-023-02118-w. Epub 2023 Oct 7. Bone Marrow Transplant. 2024. PMID: 37805626 No abstract available.
Effect of graft-versus-host disease on outcomes of HLA-haploidentical peripheral blood transplantation using post-transplant cyclophophamide.
Shimomura Y, Komukai S, Kitamura T, Sobue T, Akahoshi Y, Kanda J, Ohigashi H, Nakamae H, Hiramoto N, Nagafuji K, Tanaka T, Eto T, Ota S, Maruyama Y, Akasaka T, Matsuoka KI, Mori Y, Fukuda T, Atsuta Y, Terakura S. Shimomura Y, et al. Among authors: hiramoto n. Bone Marrow Transplant. 2024 Jan;59(1):66-75. doi: 10.1038/s41409-023-02142-w. Epub 2023 Oct 28. Bone Marrow Transplant. 2024. PMID: 37898725
132 results